DJIA 16,107.56 -420.47 -2.54%
NASDAQ 4,664.48 -112.02 -2.35%
S&P 500 1,926.05 -46.13 -2.34%
market minute promo

58.49 -0.98 (-1.65%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMY $58.49 -1.65%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $58.55
Previous Close $59.47
Daily Range $57.97 - $59.29
52-Week Range $47.55 - $70.54
Market Cap $97.5B
P/E Ratio 55.58
Dividend (Yield) $1.48 (2.5%)
Ex-Dividend Date
Dividend Pay Date
07/01/15
08/03/15
Volume 4,133,484
Average Daily Volume 6,649,728
Current FY EPS $1.81

Sector

Healthcare

Industry

Drug Makers

Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website: http://www.bms.com/

News & Commentary Rss Feed

New Skin Cancer Drugs Delayed (but Investors and Patients Needn't Worry)

FDA decisions for Bristol-Myers Sqibb's Opdivo and Merck's Keytruda get pushed back.

VHT, MRK, BMY, LLY: Large Outflows Detected at ETF

The Generation Portfolio: Wells Fargo, Disney, MFA Financial, Bristol-Myers Squibb

U.S. Food and Drug Administration Accepts for Priority Review the Biologics License Application for

U.S. Food and Drug Administration Accepts for Priority Review the Biologics License Application for Empliciti (elotuzumab) for the Treatment of Multiple Myeloma in Patients Who Have Received One or More Prior Therapies

Bristol-Myers Inks Another Immuno-Oncology Drug Deal

UPDATE 1-Bristol-Myers buys rights to acquire fibrosis drug developer

Bristol-Myers buys rights to fibrosis drug for up to $1.25 bln

Credit Suisse's 8 Pharmaceutical Stocks with 'Significant' Upside

Benzinga's M&A Chatter for Thursday August 27, 2015

Allied-Bristol Life Sciences Licenses Platform Technology and Lead Molecules from Yale University

Short Sellers Have Mixed Feelings on Major Pharma

See More BMY News...

BMY's Top Competitors

BMY $58.49 (-1.65%)
Current stock: BMY
JNJ $91.53 (-2.61%)
Current stock: JNJ
NVS $94.85 (-2.44%)
Current stock: NVS
RHHBY $33.32 (-2.44%)
Current stock: RHHBY